Health ❯ Patient Care
Treatment Options Standard Treatment Cancer Treatment Survivorship Treatment Resistance Chemotherapy Side Effects Support Systems Follow-up Treatments Biopsy Procedures Access to Treatment
A NYU Langone Health study uncovered a reliance on EGFR signaling in NF1-mutant tumors prompting early-phase trials of cetuximab plus afatinib.
